Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today statistically significant and clinically meaningful results from the Phase III ALLEGORY study of Gazyva® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback